Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8754065 Tenofovir alafenamide hemifumarate

Patent 8754065 was granted and assigned to Gilead Sciences on June, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8754065

Patent Inventor Names

Dazhan Liu0

Bing Shi0

Fang Wang0

Richard Hung Chiu Yu0

Date of Patent

June 17, 2014

Patent Application Number

13586358

Date Filed

August 15, 2012

Patent Citations Received

‌

US Patent 12122765 Methods and intermediates for preparing therapeutic compounds

‌

US Patent 11760746 Methods and intermediates for preparing therapeutic compounds

‌

US Patent 11787825 Therapeutic compounds for HIV virus infection

‌

US Patent 11833143 Choline salt forms of an HIV capsid inhibitor

‌

US Patent 11944611 Capsid inhibitors for the treatment of HIV

‌

US Patent 11993583 Therapeutic compounds

‌

US Patent 12077537 Capsid inhibitors for the treatment of HIV

‌

US Patent 12084467 Therapeutic compounds for HIV virus infection

...

Patent Primary Examiner

‌

James D. Anderson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8754065 Tenofovir alafenamide hemifumarate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API